Bromsite generic
Bromsite is a postoperative inflammation and ocular pain prevention drug owned by Sun Pharm. The active ingredient in this drug is bromfenac sodium, and it came into the market on April 8, 2016.
When will Bromsite generic be available?
Bromsite has one drug patent, none of which have already expired. The potential release date for Bromsite generic could be after August 7, 2029.
Bromsite uses
Bromsite is primarily used for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery. It's effectiveness can be attributed to its active ingredient, bromfenac sodium.
Bromsite patent expiration
Bromsite holds a patent titled 'Non-steroidal anti-inflammatory ophthalmic compositions', which expires on August 7, 2029. This patent could potentially delay the release of Bromsite generic. Below are the details of the patent: